Colonial Trust Advisors’s Prothena Corp PRTA Stock Holding History

Colonial Trust Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7	Closed	-$97	–	707
2024 Q4	$97	Buy	+7	New	+$110	﹤0.01%	664

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Colonial Trust Advisors's PRTA Position: Q1 2025 in Review

Colonial Trust Advisors sold out of Prothena Corp (PRTA) in Q1 2025, closing a stake of 7 shares — an estimated $97 sold.

Colonial Trust Advisors first reported a position in PRTA in Q4 2024 and held it in 1 quarter. The position peaked at $97 in Q4 2024. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.

Colonial Trust Advisors reported no remaining Prothena Corp position as of Q1 2025 after selling out during the quarter.
Colonial Trust Advisors sold 7 Prothena Corp shares in Q1 2025, an estimated $97.
Colonial Trust Advisors first reported a position in Prothena Corp in Q4 2024 and held it in 1 quarter.
Colonial Trust Advisors's Prothena Corp position peaked at $97 in Q4 2024.
161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.

Based on Colonial Trust Advisors's 13F filing for Q1 2025, filed 14 May 2025.